Mechanistic role of NS4A and substrate in the activation of HCV NS3 protease

被引:10
|
作者
Zhu, Haimei [1 ]
Briggs, James M. [1 ]
机构
[1] Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA
关键词
molecular dynamics; HCV NS3 protease; NS4A; activation; inhibitor; sampling reliability; catalytic triad; essential dynamics; HEPATITIS-C VIRUS; PARTICLE MESH EWALD; MOLECULAR-DYNAMICS; PROTEINASE; SIMULATIONS; DOMAIN;
D O I
10.1002/prot.23064
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hepatitis C virus (HCV) NS3 protease is the key enzyme for its maturation. Three hypotheses have been advanced in the literature to demonstrate the mechanism of the activation of the HCV NS3 protease. A virus-encoded protein NS4A and substrate are proposed to be involved in the activation of the HCV NS3 protease. However, the three hypotheses are not completely consistent with one another. Multiple molecular dynamics simulations were performed on various NS3 protease systems: free NS3 protease, NS3/4A, NS3/inhibitor, and NS3/4A/inhibitor complexes, to further unravel the mechanism of the activation of the NS3 protease. Simulation results suggest that the binding of NS4A induces a classic serine protease conformation of the catalytic triad of the NS3 protease. NS4A rearranges the secondary structure of both the N-terminus and catalytic site of the NS3 protease, reduces the mobility of the global structure of the NS3 protease, especially the catalytic site, and provides a rigid and tight structure, except for the S1 pocket, for the binding and hydrolysis of substrates. The binding of substrate also contributes to the activation of the NS3 protease by an induced-fit of the classic serine protease catalytic triad. However, the global structure of the NS3 protease is still loose and highly flexible without stable secondary structural elements, such as helix alpha 0 at the N-terminus and helix alpha 1 and beta-sheet E1-F1 at the catalytic site. The structure of the NS3 protease without NS4A is not suitable for the binding and hydrolysis of substrates.
引用
收藏
页码:2428 / 2443
页数:16
相关论文
共 50 条
  • [31] Engineering, characterization and phage display of hepatitis C virus NS3 protease and NS4A cofactor peptide as a single-chain protein
    Dimasi, N
    Pasquo, A
    Martin, F
    Di Marco, S
    Steinkühler, C
    Cortese, R
    Sollazzo, M
    PROTEIN ENGINEERING, 1998, 11 (12): : 1257 - 1265
  • [32] The N-terminal helix α0 of hepatitis C virus NS3 protein dictates the subcellular localization and stability of NS3/NS4A complex
    He, Ying
    Weng, Leiyun
    Li, Rui
    Li, Li
    Toyoda, Tetsuya
    Zhong, Jin
    VIROLOGY, 2012, 422 (02) : 214 - 223
  • [33] Sequential Phosphorylation of the Hepatitis C Virus NS5A Protein Depends on NS3-Mediated Autocleavage between NS3 and NS4A
    Chiang, Cho-Han
    Lai, Yen-Ling
    Huang, Yu-Ning
    Yu, Chun-Chiao
    Lu, Christine C.
    Yu, Guann-Yi
    Yu, Ming-Jiun
    JOURNAL OF VIROLOGY, 2020, 94 (19)
  • [34] Complex of NS3 protease and NS4A peptide of BK strain hepatitis C virus:: A 2.2 Å resolution structure in a hexagonal crystal form
    Yan, YW
    Li, Y
    Munshi, S
    Sardana, V
    Cole, JL
    Sardana, M
    Steinkuehler, C
    Tomei, L
    De Francesco, R
    Kuo, LC
    Chen, ZG
    PROTEIN SCIENCE, 1998, 7 (04) : 837 - 847
  • [35] Activity of compounds from Taxillus sutchuenensis as inhibitors of HCV NS3 serine protease
    Yang, Liyuan
    Lin, Jun
    Zhou, Bin
    Liu, Yangang
    Zhu, Baoquan
    NATURAL PRODUCT RESEARCH, 2017, 31 (04) : 487 - 491
  • [36] Potent HCV NS3 Protease Inhibition by a Water-Soluble Phyllanthin Congener
    Reddy, Uma B.
    Tandon, Himani
    Pradhan, Manoj K.
    Adhikesavan, Harikrishnan
    Srinivasan, Narayanaswamy
    Das, Saumitra
    Jayaraman, Narayanaswamy
    ACS OMEGA, 2020, 5 (20): : 11553 - 11562
  • [37] A macrocyclic HCV NS3/4A protease inhibitor interacts with protease and helicase residues in the complex with its full-length target
    Schiering, Nikolaus
    D'Arcy, Allan
    Villard, Frederic
    Simic, Oliver
    Kamke, Marion
    Monnet, Gaby
    Hassiepen, Ulrich
    Svergun, Dmitri I.
    Pulfer, Ruth
    Eder, Joerg
    Raman, Prakash
    Bodendorf, Ursula
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (52) : 21052 - 21056
  • [38] TMC-435, an NS3/4A protease inhibitor for the treatment of HCV infection
    Tsantrizos, Youla S.
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2009, 10 (08) : 871 - 881
  • [39] Redesigning the substrate specificity of the hepatitis C virus NS3 protease
    Failla, CM
    Pizzi, E
    DeFrancesco, R
    Tramontano, A
    FOLDING & DESIGN, 1996, 1 (01): : 35 - 42
  • [40] BI-201335 Treatment of Hepatitis C Virus Serine Protease NS3/Non-Structural Protein 4A (NS4A) Inhibitor
    Vachon, Marie-Louise
    DRUGS OF THE FUTURE, 2012, 37 (02) : 99 - 109